# Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal Polyps

> **NCT07046117** · NA · NOT_YET_RECRUITING · sponsor: **Medical University of Vienna** · enrollment: 20 (estimated)

## Conditions studied

- Asthma Bronchiale
- Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

## Interventions

- **DRUG:** Tezepelumab

## Key facts

- **NCT ID:** NCT07046117
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2028-01-31
- **Final completion:** 2028-08-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07046117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07046117, "Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal Polyps". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07046117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*